Monsenso A/S (CPH:MONSO)
0.1300
+0.0150 (13.04%)
Nov 6, 2025, 4:59 PM CET
Monsenso Revenue
Monsenso had revenue of 5.17M DKK in the half year ending June 30, 2025, with 17.17% growth. This brings the company's revenue in the last twelve months to 10.80M, up 0.58% year-over-year. In the year 2024, Monsenso had annual revenue of 11.17M with 16.01% growth.
Revenue (ttm)
10.80M
Revenue Growth
+0.58%
P/S Ratio
0.90
Revenue / Employee
900.33K
Employees
13
Market Cap
9.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.17M | 1.54M | 16.01% |
| Dec 31, 2023 | 9.62M | 3.41M | 54.90% |
| Dec 31, 2022 | 6.21M | -930.00K | -13.02% |
| Dec 31, 2021 | 7.14M | -1.92M | -21.19% |
| Dec 31, 2020 | 9.06M | 283.00K | 3.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.87B |
| H. Lundbeck | 23.52B |
| Genmab | 23.16B |
| Demant | 22.59B |
| GN Store Nord | 17.33B |
| Zealand Pharma | 9.11B |
| Bavarian Nordic | 6.46B |